Targeted expression of islet neogenesis associated protein to beta cells enhances glucose tolerance and confers resistance to streptozotocin-induced hyperglycemia

Molecular and Cellular Endocrinology

Volumn 335, Issue 2, 2011, Pages 104-109

  Chang, Tien Jyun ^a   Weaver, Jessica R ^a   Bowman, Angela ^a   Leone, Kendall ^a   Raab, Rebekah ^a   Vinik, Aaron I ^a   Pittenger, Gary L ^a   Taylor Fishwick, David A ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Diabetes; INGAP; Insulin sensitivity; NADPH oxidase; Neogenesis; Streptozotocin

Indexed keywords

CYTOKINE; GLUCOSE; ISLET NEOGENESIS ASSOCIATED PROTEIN; PEPTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL FUNCTION; CELL PROTECTION; CONTROLLED STUDY; DISEASE COURSE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; HYPERGLYCEMIA; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; TRANSGENIC MOUSE;

ANIMALS; BLOOD GLUCOSE; CASPASE 3; DIABETES MELLITUS, EXPERIMENTAL; GENE EXPRESSION REGULATION; GLUCOSE; HYPERGLYCEMIA; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; MALE; MICE; MICE, TRANSGENIC; NADH, NADPH OXIDOREDUCTASES; PROTEINS; RECOMBINANT PROTEINS; STREPTOZOCIN; TRANSCRIPTION, GENETIC;

EID: 79951724721     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.12.026     Document Type: Article

References (41)

1. Arnush M., Heitmeier M.R., Scarim A.L., Marino M.H., Manning P.T., Corbett J.A. IL-1 produced and released endogenously within human islets inhibits beta cell function. J. Clin. Invest. 1998, 102(3):516-526.
2. Barbosa H., Bordin S., Stoppiglia L., Silva K., Borelli M., Del Zotto H., Gagliardino J., Boschero A. Islet neogenesis associated protein (INGAP) modulates gene expression in cultured neonatal rat islets. Regul. Pept. 2006, 136(1-3):78-84.
3. Barbosa H.C., Bordin S., Anhe G., Persaud S.J., Bowe J., Borelli M.I., Gagliardino J.J., Boschero A.C. Islet neogenesis-associated protein signaling in neonatal pancreatic rat islets: involvement of the cholinergic pathway. J. Endocrinol. 2008, 199(2):299-306.
4. Bell G.I., Polonsky K.S. Diabetes mellitus and genetically programmed defects in beta-cell function. Nature 2001, 414(6865):788-791.
5. Butler A.E., Janson J., Bonner-Weir S., Ritzel R., Rizza R.A., Butler P.C. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003, 52(1):102-110.
6. D'Hertog W., Overbergh L., Lage K., Ferreira G.B., Maris M., Gysemans C., Flamez D., Cardozo A.K., Van den Bergh G., Schoofs L., Arckens L., Moreau Y., Hansen D.A., Eizirik D.L., Waelkens E., Mathieu C. Proteomics analysis of cytokine-induced dysfunction and death in insulin-producing INS-1E cells: new insights into the pathways involved. Mol. Cell. Proteomics 2007, 6(12):2180-2199.
7. Donath M.Y., Storling J., Berchtold L.A., Billestrup N., Mandrup-Poulsen T. Cytokines and beta-cell biology: from concept to clinical translation. Endocr. Rev. 2008, 29(3):334-350.
8. Dungan K.M., Buse J.B., Ratner R.E. Effects of therapy in type 1 and type 2 diabetes mellitus with a peptide derived from islet neogenesis associated protein (INGAP). Diabetes Metab. Res. Rev. 2009, 25(6):558-565.
9. Eizirik D.L., Colli M.L., Ortis F. The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat. Rev. Endocrinol. 2009, 5(4):219-226.
10. Fleming A., Rosenberg L. Prospects and challenges for islet regeneration as a treatment for diabetes: a review of islet neogenesis associated protein. J. Diabetes Sci. Technol. 2007, 1:231-244.
11. Goldstein B.J., Mahadev K., Wu X. Redox paradox: insulin action is facilitated by insulin-stimulated reactive oxygen species with multiple potential signaling targets. Diabetes 2005, 54(2):311-321.
12. Hamblet N.S., Shi W., Vinik A.I., Taylor-Fishwick D.A. The Reg family member INGAP is a marker of endocrine patterning in the embryonic pancreas. Pancreas 2008, 36(1):1-9.
13. Hotamisligil G.S. Inflammation and endoplasmic reticulum stress in obesity and diabetes. Int. J. Obes. (Lond.) 2008, 32(Suppl. 7):S52-S54.
14. Kim J.A., Wei Y., Sowers J.R. Role of mitochondrial dysfunction in insulin resistance. Circ. Res. 2008, 102(4):401-414.
15. Lambeth J.D., Krause K.H., Clark R.A. NOX enzymes as novel targets for drug development. Semin. Immunopathol. 2008, 30(3):339-363.
16. McEvoy R.C., Andersson J., Sandler S., Hellerstrom C. Multiple low-dose streptozotocin-induced diabetes in the mouse. Evidence for stimulation of a cytotoxic cellular immune response against an insulin-producing beta cell line. J. Clin. Invest. 1984, 74(3):715-722.
17. 2-induced mouse islet or clonal pancreatic β-cell dysfunction. Biosci. Rep. 2010, 30(6):445-453.
18. Morgan D., Oliveira-Emilio H.R., Keane D., Hirata A.E., Santos da Rocha M., Bordin S., Curi R., Newsholme P., Carpinelli A.R. Glucose, palmitate and pro-inflammatory cytokines modulate production and activity of a phagocyte-like NADPH oxidase in rat pancreatic islets and a clonal beta cell line. Diabetologia 2007, 50(2):359-369.
19. Morgan D., Rebelato E., Abdulkader F., Graciano M.F., Oliveira-Emilio H.R., Hirata A.E., Rocha M.S., Bordin S., Curi R., Carpinelli A.R. Association of NAD(P)H oxidase with glucose-induced insulin secretion by pancreatic beta-cells. Endocrinology 2009, 150(5):2197-2201.
20. Nakayama M., Inoguchi T., Sonta T., Maeda Y., Sasaki S., Sawada F., Tsubouchi H., Sonoda N., Kobayashi K., Sumimoto H., Nawata H. Increased expression of NAD(P)H oxidase in islets of animal models of Type 2 diabetes and its improvement by an AT1 receptor antagonist. Biochem. Biophys. Res. Commun. 2005, 332(4):927-933.
21. Newsholme P., Haber E.P., Hirabara S.M., Rebelato E.L., Procopio J., Morgan D., Oliveira-Emilio H.C., Carpinelli A.R., Curi R. Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity. J. Physiol. 2007, 583(Pt. 1):9-24.
22. Newsholme P., Morgan D., Rebelato E., Oliveira-Emilio H.C., Procopio J., Curi R., Carpinelli A. Insights into the critical role of NADPH oxidase(s) in the normal and dysregulated pancreatic beta cell. Diabetologia 2009, 52(12):2489-2498.
23. Oliveira H.R., Verlengia R., Carvalho C.R., Britto L.R., Curi R., Carpinelli A.R. Pancreatic beta-cells express phagocyte-like NAD(P)H oxidase. Diabetes 2003, 52(6):1457-1463.
24. Pi J., Bai Y., Zhang Q., Wong V., Floering L.M., Daniel K., Reece J.M., Deeney J.T., Andersen M.E., Corkey B.E., Collins S. Reactive oxygen species as a signal in glucose-stimulated insulin secretion. Diabetes 2007, 56(7):1783-1791.
25. Pipeleers D., Hoorens A., Marichal-Pipeleers M., Van de Casteele M., Bouwens L., Ling Z. Role of pancreatic beta-cells in the process of beta-cell death. Diabetes 2001, 50(Suppl. 1):S52-S57.
26. Pittenger G.L., Taylor-Fishwick D.A., Johns R.H., Burcus N., Kosuri S., Vinik A.I. Intramuscular injection of islet neogenesis-associated protein peptide stimulates pancreatic islet neogenesis in healthy dogs. Pancreas 2007, 34(1):103-111.
27. Pittenger G.L., Taylor-Fishwick D.A., Vinik A.I. A role for islet neogenesis in curing diabetes. Diabetologia 2009, 52(5):735-738. Epub 2009 Mar 7.
28. Rosenberg L., Lipsett M., Yoon J.W., Prentki M., Wang R., Jun H.S., Pittenger G.L., Taylor-Fishwick D., Vinik A.I. A pentadecapeptide fragment of islet neogenesis-associated protein increases beta-cell mass and reverses diabetes in C57BL/6J mice. Ann. Surg. 2004, 240(5):875-884.
29. Rossini A.A., Like A.A., Chick W.L., Appel M.C., Cahill G.F. Studies of streptozotocin-induced insulitis and diabetes. Proc. Natl. Acad. Sci. U.S.A. 1977, 74(6):2485-2489.
30. 2+ handling in cultured adult rat islets. Regul. Pept. 2008, 148(1-3):39-45.
31. Taylor-Fishwick D., Pittenger G.L., Vinik A.I. Transplantation and beyond. Drug Dev. Res. 2008, 69:165-176.
32. Taylor-Fishwick D.A., Bowman A., Hamblet N., Bernard P., Harlan D.M., Vinik A.I. Islet neogenesis associated protein transgenic mice are resistant to hyperglycemia induced by streptozotocin. J. Endocrinol. 2006, 190(3):729-737.
33. Taylor-Fishwick D.A., Bowman A., Korngiebel-Rosique M., Vinik A.I. Pancreatic islet immunoreactivity to the Reg protein INGAP. J. Histochem. Cytochem. 2008, 56(2):183-191.
34. Taylor-Fishwick D.A., Rittman S., Kendall H., Roy L., Shi W., Cao Y., Pittenger G.L., Vinik A.I. Cloning genomic INGAP: a Reg-related family member with distinct transcriptional regulation sites. Biochim. Biophys. Acta 2003, 1638(1):83-89.
35. Taylor-Fishwick D.A., Shi W., Hughes L., Vinik A. Pdx-1 regulation of the INGAP promoter involves sequestration of NeuroD into a non-DNA-binding complex. Pancreas 2010, 39(1):64-70.
36. Taylor-Fishwick D.A., Shi W., Pittenger G.L., Vinik A.I. PDX-1 can repress stimulus-induced activation of the INGAP promoter. J. Endocrinol. 2006, 188(3):611-621.
37. Tiedge M., Lortz S., Drinkgern J., Lenzen S. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes 1997, 46(11):1733-1742.
38. Uchizono Y., Takeya R., Iwase M., Sasaki N., Oku M., Imoto H., Iida M., Sumimoto H. Expression of isoforms of NADPH oxidase components in rat pancreatic islets. Life Sci. 2006, 80(2):133-139.
39. Vinik A.I., Rosenberg L., Pittenger G.L., Taylor-Fishwick D.A. Stimulation of pancreatic islet neogenesis: a possible treatment for type 1 and type 2 diabetes. Curr. Opin. Endocrinol. Diabetes 2004, 11:125-140.
40. Wellen K.E., Hotamisligil G.S. Inflammation, stress, and diabetes. J. Clin. Invest. 2005, 115(5):1111-1119.
41. West I.C. Radicals and oxidative stress in diabetes. Diabet. Med. 2000, 17(3):171-180.